Current Research and Scholarly Interests
During my tenure as Medical Director of the Stanford Cancer Institute (2010-15)
The Patient Experience, as measured by the Press-Ganey question “Likelihood to Recommend the Institution” for care, increased from the ninth percentile to consistently above the 90 percentile.
I co-led a task force that developed a strategic plan for the clinical operations of SCI, which was incorporated into a larger plan to transform cancer care at Stanford and nationwide. This plan resulted in a large gift, a substantial portion of which is allocated to Transform Cancer Care at Stanford and the nation (“the Transformation”).
Growth, as measured by new patient visits, increased by eleven percent year over year starting in fiscal year 2012, the year in which we set a goal to grow by fifty percent by 2017.
Stanford’s Cancer Program has increased its ranking to number 10 in the nation for 2014 in the US News and World Report’s (USNWR) latest ranking of cancer programs. Stanford ranked 14th in 2011. Cancer is the highest ranked Stanford Program in the USNWR system.